TY - JOUR
T1 - Pharmaceutical Policy in the UK
AU - Kay, Adrian
PY - 2001
Y1 - 2001
N2 - For many years drug price regulation posed few public management problems. However, the overall NHS drugs budget has been increasing by almost 9% per annum over the past decade. Governments in the 1990s tried to control this growth by introducing new pharmaceutical policy instruments. This has led to an element of instability in the regulation of the pharmaceutical industry, which is affecting NHS financial programming, as well as R&D investment decisions by companies. This article recommends the creation of an office for drug regulation (an ‘OFDRUG’) to reintroduce stability into pharmaceutical policy.
AB - For many years drug price regulation posed few public management problems. However, the overall NHS drugs budget has been increasing by almost 9% per annum over the past decade. Governments in the 1990s tried to control this growth by introducing new pharmaceutical policy instruments. This has led to an element of instability in the regulation of the pharmaceutical industry, which is affecting NHS financial programming, as well as R&D investment decisions by companies. This article recommends the creation of an office for drug regulation (an ‘OFDRUG’) to reintroduce stability into pharmaceutical policy.
UR - https://www.tandfonline.com/doi/abs/10.1111/1467-9302.00285
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-0035601320&partnerID=MN8TOARS
U2 - 10.1111/1467-9302.00285
DO - 10.1111/1467-9302.00285
M3 - Article
SN - 0954-0962
VL - 21
SP - 51
EP - 54
JO - Public Money and Management
JF - Public Money and Management
IS - 4
ER -